Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» UCB Pharmaceuticals
UCB Pharmaceuticals
Briviact (Brivaracetam) Wins Approval to Treat Partial-Onset (Focal) Seizures in Pediatric Epilepsy Patients
Mon, 05/14/18 - 08:57 am
UCB Pharmaceuticals
Briviact
epilepsy
pediatric epilepsy
UCB Receives Positive CHMP Opinion for Cimzia in Moderate-to-Severe Plaque Psoriasis
Sat, 04/28/18 - 11:55 am
UCB Pharmaceuticals
Cimzia
psoriasis
Record Pharma-Deal Year Not Enough to Sell Mature Drugs
Bloomberg
Fri, 12/19/14 - 08:22 am
Sanofi
GSK
UCB Pharmaceuticals
UCB Cancels Sale of Generic-Drug Unit to Buyout Firms
Bloomberg
Wed, 12/17/14 - 08:04 am
UCB Pharmaceuticals
M&A
generics
UCB Reports Phase III Data on Epilepsy Drug, To File in 2015
Yahoo/Zacks.com
Tue, 12/9/14 - 04:05 pm
UCB Pharmaceuticals
epilepsy
brivaracetam
UCB to Sell U.S. Generic Unit to Advent, Avista Capital
Bloomberg
Fri, 11/7/14 - 07:48 am
UCB Pharmaceuticals
M&A
generics
Advent International
Avista Capital
UCB-Amgen Reveals Positive Data on Romosozumab for PMO
Yahoo/Zacks.com
Thu, 09/18/14 - 09:17 am
Amgen
UCB Pharmaceuticals
romosozumab
low bone mineral density
UCB’s epilepsy drug approved as monotherapy in US
Pharmaphorum
Tue, 09/2/14 - 08:09 am
UCB Pharmaceuticals
FDA
epilepsy
Vimpat
UCB hops on pharma's spinoff wagon with potential $2B sale of generics business
Fierce Pharma
Thu, 08/7/14 - 08:32 am
generics
UCB Pharmaceuticals
M&A
Kremers Urban Pharmaceuticals
UCB inches toward the FDA with its latest epilepsy contender
Fierce Biotech
Thu, 07/24/14 - 09:56 am
UCB Pharmaceuticals
FDA
epilepsy
brivaracetam
Drugmakers to share neglected compounds with British academia
Yahoo/Reuters
Tue, 07/22/14 - 08:47 am
UK
R&D
AstraZeneca
GSK
JNJ
Eli Lilly
Pfizer
Takeda
UCB Pharmaceuticals
UCB's Vimpat Positive for Partial-Onset Seizures
Yahoo/Zacks.com
Mon, 06/30/14 - 11:07 am
UCB Pharmaceuticals
partial seizures
Vimpat
UCB Sales Rise in Q1
Yahoo/Zacks.com
Thu, 04/24/14 - 05:55 pm
UCB Pharmaceuticals
earnings
Sanofi, UCB enter small-molecule drug development deal for immune-mediated diseases
First Word Pharma
Tue, 03/11/14 - 08:37 am
Sanofi
UCB Pharmaceuticals
small molecule drugs
drug development
The top 10 pharma companies in social media
Fierce Pharma Marketing
Wed, 02/5/14 - 09:55 am
social media
JNJ
GSK
Novo Nordisk
UCB Pharmaceuticals
Pfizer
Boehringer Ingelheim
Novartis
Bayer
Merck
AstraZeneca
A Unique Take On Pharmaceutical Research
Bioresearch Online
Sat, 02/1/14 - 11:14 am
UCB Pharmaceuticals
Amgen Vs. Merck, Lilly In Osteoporosis Competition
Seeking Alpha
Thu, 01/9/14 - 08:33 am
Amgen
Merck
Eli Lilly
osteoporosis
romosozumab
UCB Pharmaceuticals
Prolia
Forteo
Fosamax
UCB Not for Sale as Billionaire Shareholder Awaits Reward
Bloomberg
Wed, 11/27/13 - 09:06 pm
M&A
UCB Pharmaceuticals
FDA panel narrowly backs new use of UCB's arthritis drug
Reuters
Wed, 07/24/13 - 09:49 am
FDA
UCB Pharmaceuticals
rheumatoid arthritis
certolizumab
UCB Visited by Chinese Authorities Amid Glaxo Probe
Bloomberg
Fri, 07/19/13 - 10:19 am
UCB Pharmaceuticals
GSK
China
Pages
1
2
3
next ›
last »